Mobile Menu

Dots connected.
Problems solved.
Everyone wins.
This is Connective Capital.

Echo is an investment firm generating exceptional financial and social returns by connecting overlooked domestic resources and infrastructure with world-class founders, ideas, and capital.

Private Equity

Private Equity

Learn More
Venture

Venture

Learn More
Impact

Impact

Learn More

News


January 30, 2023

Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application

Deka Biosciences ("Deka"), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has completed its review of the investigational new drug (IND) application for DK210 (EGFR) and concluded that Deka may proceed with a Phase 1 clinical trial in the United States.

Read More

December 12, 2022

CBS: Oklahoma incentives lure TV & film productions out of Hollywood and to the prairie

Is Hollywood moving to the prairie? Omar Villafranca takes a look at how Oklahoma state incentives are bringing motion-picture production to the state.

Read More

Let’s build something great together.